A corona vaccine developed by the Danish Statens Serum Institut (SSI) is now ready to be tested on humans, the Danish Ministry of Health states.
The authorities have allocated almost DKK 19 million, corresponding to just over NOK 27 million, to develop the vaccine further.
“If it has the potential to be approved, the vaccine will eventually be tested on a large scale,” Minister of Health Magnus Heunicke noted in a statement.
“But no matter the outcome of the tests, the development of a vaccine at SSI will help strengthen the knowledge about COVID-19.
“It will better equip us for the development of future virus vaccines against future pandemics,” he said.
In the first clinical test phases, a larger number of the vaccine will be produced.
If the other test phases are successful, it will eventually be evaluated by the European Medicines Agency (EMA).
It will eventually be approved as a valid COVID-19 vaccine only if there is sufficient evidence of its efficacy and safety.
The news comes a few days after the American pharmaceutical giant Pfizer and German BioNTech announced that the vaccine they have been working on together seems to be successful.
On Tuesday, the EU agreed with the pharmaceutical giants on an agreement that includes the procurement of 200 million doses, with an option of another 100 million.
© NTB Scanpix / #Norway Today